Navigation Links
SimplyThick Necrotizing Enterocolitis Allegations Lawsuits Now Being Investigated by Resource4thePeople Attorneys

San Diego, CA (PRWEB) March 22, 2013

Resource4thePeople announced today that its lawyers are now investigating side effects from the SimplyThick thickening product that government officials* say may be putting infants at risk of suffering a life-threatening illness called necrotizing enterocolitis (NEC).

A growing number of consumer inquiries have been received since the Food and Drug Administration issued a national alert* warning parents, caregivers and health care professionals to be aware that infants of any age may face an increased risk of developing a life-threatening condition if fed a thickening product called SimplyThick.

“There is a substantial number of families who may have been affected by the side effects cited by the Food and Drug Administration and many of them have been contacting us for information about this problem and what their legal options may be,” said Resource4thePeople.

“Because of this steady volume of inquiries from concerned parents over the medical problems that their infants may have suffered our attorneys are now actively investigating these SimplyThick NEC cases.

“Our experienced legal team is now available to provide free consultations about what legal options may be available to those eligible to seek compensation for medical costs, pain and suffering, loss of wages and other expenses that may have been incurred.”

In its announcement* the FDA said that since May 2011, the agency has identified 22 infants who developed NEC, a condition in which tissue in the intestines becomes inflamed and dies, after being fed SimplyThick. Seven of those infants died.

The agency said that further study is needed to determine if there is an actual link between consumption of SimplyThick and the development of NEC and that the results of that research will be announced to the public and health care professionals.

“But, FDA wants everyone involved in the care of a baby to be aware of the potential risk before deciding whether to feed SimplyThick to infants of any age,” the agency said.

The FDA described SimplyThick as a brand of thickening agent—available to consumers and medical centers—used to help manage swallowing difficulties.

It is sold in individual serving packets as well as in 64-ounce dispenser bottles, which can be purchased from distributors and local pharmacies throughout the United States.

The agency said Benson M. Silverman, M.D., director of FDA's Infant Formula and Medical Foods Staff—himself a neonatologist—explained that the thickening agent is added to breast milk and infants' formula to help the premature babies swallow their food and keep it down, without spitting up.

The product is also used in older children and adults with swallowing problems caused by trauma to the throat, he said.

Our experienced, aggressive lawyers are now investigating claims from families who have children who have been affected by this product. Please contact us as soon as possible to ensure that all of your legal rights are protected.

Resource4thePeople is informing consumers that there may be time limits involved in certain cases and the earlier that an inquiry is made about a free consultation the more effectively our lawyers can begin pursuing compensation in cases in which eligibility is determined.

“Our experienced, aggressive lawyers are now investigating claims from families who have children who may have been affected by this product,” said Resource4thePeople. “This is a very serious illness that has been documented by the FDA as causing deaths in infants.”

Resource4thePeople also is alerting parents who may have fed their infants SimplyThick about the most commonly reported symptoms of NEC:

  •     Distended abdomen
  •     Greenish-tinged vomit
  •     Bloated stomach
  •     Diarrhea
  •     Vomiting
  •     Blood in stools
  •     Lethargy
  •     Feeding intolerance
If a baby is exhibiting those symptoms Resource4thePeople urges all parents to immediately contact their health care professional for a diagnosis.

The FDA said that it first learned of bad side effects possibly linked to SimplyThick on May 13, 2011. Dr. Silverman says he was alerted by two reports in FDA's MedWatch Safety Information and Adverse Event Reporting Program. He followed up with the physicians who filed those reports and later with a network of other neonatologists, doctors who treat newborns in need of special care.

Karl Klontz, M.D., a medical officer in FDA's Center for Food Safety and Applied Nutrition, says the scope of the problem soon became apparent. At the time, the agency was aware of 15 cases of NEC, including two deaths, involving premature infants who were fed SimplyThick, reportedly as directed, mixed with mothers' breast milk or infant formula products. The mixture was fed to infants for varying amounts of time.



Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. IOC Takes Decisive Action on Ticketing Allegations
2. Medtronic Infuse Bone Graft Questioned As Allegations Unfold – Bisnar
3. Chase Attorneys Offer Free Consultations
4. Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
5. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
6. DrugRisk Announces Updated Information on Mirena Lawsuits
7. Nexium MDL Consolidated for Bone Fracture Lawsuits: AttorneyOne Informs
8. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
9. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
10. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
11. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: